Using artificial intelligence (AI) to analyze biopsies of the salivary glands in people with Sjögren’s disease may help identify…
Articles by Marisa Wexler, MS
Efgartigimod is entering a Phase 3 clinical trial after data from a proof-of-concept Phase 2 trial showed it outperformed a…
A study found significant associations between eye surface changes and alterations in immune activity throughout the body in people with primary…
Cullinan Therapeutics is planning the launch of a clinical trial in the U.S. to test its treatment candidate CLN-978…
Immunovant is planning to launch a potentially registrational clinical trial this summer to test its treatment candidate IMVT-1402 in…
April is Sjögren’s Awareness Month, and a U.S.-based nonprofit is gearing up to help the community spread the word…
A rare condition called cerebral venous thrombosis or CVT, characterized by blood clots forming in veins in the brain, can…
Changes in the metabolic activity of certain immune cells may help to drive the inflammatory attacks that cause Sjögren’s…
Injecting the salivary glands with stem cells derived from fatty tissue was shown to ease the symptoms of Sjögren’s…
Telitacicept, RemeGen’s experimental under-the-skin injection therapy, significantly reduced disease severity in adults with primary Sjögren’s syndrome (pSS),…